Last reviewed · How we verify

NCT05503238

The Effects of Mother-infant Skin-to-skin Contact on Stress Response of Preterm Infants

Withdrawn NA Last updated 24 February 2025
What this trial tests

NA trial testing Skin-to-skin contact in Preterm Infant. Withdrawn.

Timeline
1 December 2025
Primary endpoint
31 May 2026
30 June 2026

Quick facts

Lead sponsorChildren's Hospital of Fudan University
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Start date1 December 2025
Primary completion31 May 2026
Estimated completion30 June 2026
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Children's Hospital of Fudan University

Who can join

Adults 0 Hours to 24 Hours, any sex, with Preterm Infant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the effect of maternal-infant skin-to-skin contact (SSC) versus routine care on general stress in preterm infants in the neonatal intensive care unit (NICU).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Skin-to-skin contact

Trials testing the same drug.

Other recruiting trials for Preterm Infant

Currently open trials in the same condition.

Other Children's Hospital of Fudan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05503238.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing